ICON Cash Flow Statement
NASDAQ: ICLRHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ICON free cash flow
In fiscal 2025, ICON generated $1.04 billion of operating cash flow and spent $174.2 million on capital expenditures. That left free cash flow of $862.0 million, a free-cash-flow margin of 10.4% of revenue. Free cash flow was down 22.9% from the prior year's $1.12 billion.
ICON returned $750.0 million to shareholders through share repurchases, equal to 87% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
ICON cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 229.34M | 739.13M | 554.21M | 505.30M | 153.19M | 332.96M | 375.86M | 322.66M | 281.49M | 262.18M |
| Net Income growth (YoY) | -68.97% | +33.37% | +9.68% | +229.87% | -53.99% | -11.41% | +16.49% | +14.63% | +7.36% | +9.45% |
| Depreciation & Amortization | 383.00M | 488.50M | 585.95M | 569.51M | 314.99M | 66.13M | 61.55M | 65.92M | 61.30M | 59.58M |
| Stock-Based Compensation | 102.04M | 45.87M | 55.67M | 70.52M | 133.84M | 26.27M | 26.82M | 31.59M | 30.57M | 40.34M |
| Change in Working Capital | -39.70M | 235.83M | -10.86M | -227.75M | 44.39M | 131.82M | -15.12M | -52.11M | 61.95M | -40.18M |
| Operating Cash Flow | 1.04B | 1.29B | 1.16B | 563.32M | 829.14M | 568.03M | 412.54M | 268.64M | 383.08M | 259.20M |
| Capital Expenditures | -174.21M | -168.06M | -140.69M | -142.16M | -93.75M | -40.88M | -38.95M | -48.40M | -44.72M | -42.60M |
| Investing Cash Flow | -187.53M | -266.79M | -226.65M | -145.87M | -6.02B | -46.58M | -162.03M | -37.30M | -177.81M | -74.81M |
| Share Repurchases | -750.00M | -500.00M | 0 | -99.98M | 0 | -175.00M | -146.93M | -128.96M | -133.11M | -110.00M |
| Debt Repaid | — | -373.00M | -315.00M | -75.00M | — | — | — | — | — | — |
| Financing Cash Flow | -771.26M | -837.18M | -844.04M | -864.17M | 5.11B | -208.33M | -125.41M | -113.02M | -119.28M | -93.71M |
| Net Change in Cash | 108.51M | 160.68M | 89.33M | -463.44M | -88.09M | 320.00M | 124.46M | 112.99M | 90.32M | 88.63M |
| Free Cash Flow | 861.99M | 1.12B | 1.02B | 421.15M | 735.39M | 527.15M | 373.59M | 220.24M | 338.37M | 216.60M |
This table shows 10 annual periods of ICON's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ICLR's reporting calendar. What is a cash flow statement?